UNSPSC 51373427: Chlorpheniramine/codeine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373427 Chlorpheniramine/codeine/pseudoephedrine is a Commodity code that captures state and local procurement of controlled and over-the-counter pharmaceutical products for healthcare delivery within correctional facilities, community health programs, and emergency response systems. Recent solicitations show state and local governments buying parenteral pharmaceutical products (intravenous solutions, total parenteral nutrition preparations, and controlled substances for incarcerated populations), naloxone for opioid-overdose response, and associated medical delivery and deactivation systems. Issuing bodies include state departments of corrections, county health departments, and community health agencies operating across multiple facilities and jurisdictions. The Washington State Department of Corrections appears as a significant repeat buyer, managing procurement across eight correctional facilities spanning three geographic regions with multiple contractor awards anticipated per region.

Geographic activity centers on Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with responses due October 7, 2026, seeking parenteral products and services for delivery to correctional facilities in Stafford Creek, Clallam Bay, Monroe Complex, Washington Correction Center West, Washington Correction Center for Women, Airway Heights, Coyote Ridge, and Washington State Penitentiary, with contract performance beginning November 26, 2026 through June 30, 2030 and fixed pricing for the initial two-year term. The Washington procurement emphasizes rapid delivery (parenteral nutrition within 24 hours; other products within 8 hours) and requires pre-qualification through state business licensure and Washington State Patrol clearance. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Washington opportunity carries explicit set-aside preferences (25% small business, 10% minority-owned, 6% women-owned, 5% veteran-owned) and requires substantial commercial general liability and professional liability insurance; the Seminole County procurement does not name set-aside designations but carries E-Verify and drug-free workplace compliance requirements.